Suvratoxumab (MEDI4893) is a long-acting, high-affinity human anti-alpha-toxin monoclonal antibody (IgG1kappa type). Suvratoxumab potently neutralizes alpha-toxin, a key S. aureus virulence factor. Suvratoxumab improves survival and reduces lung injury in an immunocompromised mice model of pneumonia. Suvratoxumab also enhances the antibacterial activity of Vancomycin (HY-B0671) or Linezolid (HY-10394)[1][2][3].
Molekulargewicht:
(145.54 kDa)
Reinheit:
98.79
CAS Nummer:
[1629620-18-3]
Target-Kategorie:
Bacterial
Anwendungsbeschreibung:
MCE Product type: Inhibitory Antibodies
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten